Rein Therapeutics (RNTX) Enterprise Value (2017 - 2026)
Rein Therapeutics (RNTX) posted Enterprise Value of $26.14 million for Q2 2026, down 1.5% from $26.54 million a year earlier and down 18.3% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Enterprise Value (2017 - 2026) Analysis & Trends
For FY2025, Rein Therapeutics' Enterprise Value came in at $28.74 million, up 1.2% from FY2024.
- Annual Enterprise Value shows a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- In prior years, Rein Therapeutics' Enterprise Value was $28.39 million in FY2024, -$2.44 million in FY2023, -$10.48 million in FY2022 and $5.06 million in FY2021 (-77.5%).
- Quarterly Enterprise Value has run from a low of -$11.09 million in Q1 2023 to a high of $59.05 million in Q3 2024 over five years.
- On a year-over-year basis, Enterprise Value increased in two of the last six quarters, with an average decline of 19.0%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q3 2021, with growth of 7.6%; the weakest was Q1 2022, with a decline of 87.2%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $32.01 million (Q1 2026), $28.74 million (Q4 2025) and $24.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Rein Therapeutics | 48.30 Mn | 48.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.14 Mn |
| Mar 31, 2026 | 32.01 Mn |
| Dec 31, 2025 | 28.74 Mn |
| Sep 30, 2025 | 24.61 Mn |
| Jun 30, 2025 | 26.54 Mn |
| Mar 31, 2025 | 31.52 Mn |
| Dec 31, 2024 | 28.39 Mn |
| Sep 30, 2024 | 59.05 Mn |
| Jun 30, 2024 | 37.98 Mn |
| Mar 31, 2024 | 43.00 Mn |
| Dec 31, 2023 | -2.44 Mn |
| Sep 30, 2023 | -5.17 Mn |
| Jun 30, 2023 | -5.54 Mn |
| Mar 31, 2023 | -11.09 Mn |
| Dec 31, 2022 | -10.48 Mn |
| Sep 30, 2022 | -6.68 Mn |
| Jun 30, 2022 | -8.77 Mn |
| Mar 31, 2022 | 8.43 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 40.15 Mn |
API Access
Rein Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();